- Illustrations
- Specialized Illustrations
- Cellular and molecular processes
- High-Resolution Human LDL Particle
High-Resolution Human LDL Particle
Cross-section view of the lipid core of the human low density lipoprotein.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Rendered as a high-resolution cross-section through a human low density lipoprotein (LDL) particle, the cut surface exposes a central hydrophobic lipid core packed with cholesteryl esters and triglycerides. Encircling that core sits an amphipathic surface monolayer of phospholipids and unesterified (free) cholesterol, with polar head groups oriented outward toward the aqueous plasma. A single apolipoprotein B-100 chain wraps around the particle as a continuous belt, following the surface contour and defining the particle’s overall architecture. For teaching cholesterol transport, few structures are as concrete as LDL: apoB-100 is the ligand recognized by the LDL receptor, so its surface presentation links particle anatomy directly to receptor-mediated endocytosis in hepatocytes and peripheral tissues. This cross-sectional treatment also clarifies why oxidative modification and glycation of surface components can shift clearance kinetics and promote macrophage uptake through scavenger receptors, a key step in foam cell formation and atherosclerotic plaque development. Small changes in core-to-surface ratio read as changes in density. That matters clinically when you are explaining why “small, dense LDL” correlates with insulin resistance and higher cardiovascular risk. Use this asset in biochemistry and cardiovascular physiology lectures to anchor discussions of lipoprotein classes, lipid solubility constraints in plasma, and the distinction between cholesteryl ester storage versus free cholesterol at the interface. It also fits cleanly into figures for reviews on familial hypercholesterolemia (LDLR or APOB variants), PCSK9-related LDL receptor turnover, and therapeutic mechanisms of statins and PCSK9 inhibitors. Anatomical accuracy verified by SciePro's Medical Advisory Board.